NDUFA9 (NADH:Ubiquinone Oxidoreductase Subunit A9) is a core component of mitochondrial complex I (NADH:ubiquinone oxidoreductase), the largest enzyme of the mitochondrial electron transport chain. Complex I deficiency is associated with various neurodegenerative diseases including Leigh syndrome, MELAS, and Parkinson's disease.
| Property |
Value |
| Gene |
NDUFA9 |
| UniProt |
Q9P0M4 |
| Molecular Weight |
~38 kDa |
| PDB Structures |
5XDH, 6G72 |
| Subcellular Localization |
Mitochondrial inner membrane |
| Protein Family |
Complex I accessory subunits |
- Electron transfer: Transfers electrons from NADH to ubiquinone
- Proton pumping: Contributes to proton gradient generation
- ATP synthesis: Supports oxidative phosphorylation
- Cellular energy: Essential for aerobic ATP production
- Complex I assembly: Required for proper complex I assembly
- Quality control: Involved in mitochondrial quality control
- Metabolic regulation: Links metabolism to cellular signaling
- Complex I deficiency: Reduced activity leads to energy failure
- Bilateral lesions: Characteristic brainstem lesions
- Early onset: Typically presents in infancy or early childhood
¶ MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes)
- Mitochondrial dysfunction: Contributes to metabolic crisis
- Stroke-like episodes: Associated with mitochondrial energy failure
- Cognitive decline: Progressive cognitive impairment
- Complex I inhibition: Specific vulnerability of dopaminergic neurons
- Mitochondrial dysfunction: PD brains show reduced complex I activity
- Environmental toxins: Complex I inhibitors (MPTP, rotenone) cause PD-like symptoms
| Strategy |
Approach |
| Gene therapy |
AAV-delivered NDUFA9 |
| Small molecules |
Complex I activity enhancers |
| Mitochondrial antioxidants |
Protect against ROS |
| Metabolic supplements |
CoQ10, L-carnitine |
- NDUFA9 and mitochondrial complex I function. Biochimica et Biophysica Acta. 2018;1859(9):940-947.
- Complex I deficiency in neurodegeneration. Neurobiology of Aging. 2011;32(5):817-835.